Inventor · disambiguated record
W. Martin Kast
Also filed as: KAST W M · KAST W MARTIN
6 granted patents·4 pending applications·109 citations·filing 1994–2010
84Inventor score
Files withGREY HOWARD M2LUDWIG INST CANCER RES2UNIV LOYOLA CHICAGO2UNIV SOUTHERN CALIFORNIA2UNIV LEIDEN1
Top patents by PatentIndex Score
10 records- 0187US9340577B2HLA binding motifs and peptides and their usesGREY HOWARD M·Filed 2004·Granted May 17, 2016·21 cites·6 claims
- 0279US6380364B1Chimeric biotin-binding papillomavirus proteinUNIV LOYOLA CHICAGO·Filed 1999·Granted Apr 30, 2002·38 cites·17 claims
- 0373US5554724AIsolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereofUNIV LEIDEN·Filed 1994·Granted Sep 10, 1996·36 cites·4 claims
- 0460US6063900AIsolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereofLUDWIG INST CANCER RES·Filed 1996·Granted May 16, 2000·9 cites·9 claims
- 0557US2002160960A1HLA binding peptides and their usesFiled 2002·Application pending·0 cites
- 0654US2008260762A1HLA binding motifs and peptides and their usesGREY HOWARD M·Filed 2007·Application pending·0 cites
- 0742US2011077263A1Methods and Compositions of Toll-Like Receptor (TLR) AgonistsUNIV SOUTHERN CALIFORNIA·Filed 2010·Application pending·0 cites
- 0839US2011086044A1Compositions and Methods to Inhibit HPV InfectionUNIV SOUTHERN CALIFORNIA·Filed 2010·Application pending·0 cites
- 0935US6147187AIsolated tumor rejection antigen precursor mage-2 derived peptides and uses thereofLUDWIG INST CANCER RES·Filed 1998·Granted Nov 14, 2000·4 cites·9 claims
- 1031US6242176B1Papillomavirus cellular receptorUNIV LOYOLA CHICAGO·Filed 1999·Granted Jun 5, 2001·1 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when W. Martin Kast files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →